When did ARMATA PHARMACEUTICALS INC (ARMP) report earnings last quarter?
ARMATA PHARMACEUTICALS INC (ARMP) last reported earnings on 3/19/2026.
ARMATA PHARMACEUTICALS INC (ARMP) Earnings History & Surprises
NYSEARCA:ARMP • US04216R1023
Current stock price
10.18 USD
-0.38 (-3.6%)
Last:
ARMP Earnings overview
Past quarterly earnings results for ARMATA PHARMACEUTICALS INC (ARMP), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 12, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.29
- Revenue Estimate
- 754.8K
Last Reported
Most Recent- Release Date
- Mar 19, 2026
- Period
- Q3 / 2025
- EPS Reported
- -$0.74
- EPS Surprise
- -72.74%
- Revenue Surprise
- -17.68%
Beat Rate
Last 8 Quarters 44%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.74 | -0.43 | -72.74% | -393.33% | 1.159M | 1.408M | -17.68% | -61.02% |
| Q2 2025 | -0.45 | -0.40 | -13.12% | -280.00% | 2.169M | 1.408M | 54.05% | - |
| Q1 2025 | -0.20 | -0.39 | 48.40% | 71.01% | 491K | 1.408M | -65.13% | -49.17% |
| Q4 2024 | 0.07 | -0.36 | 119.61% | 112.73% | 1.235M | 1.591M | -22.38% | -19.18% |
| Q3 2024 | -0.15 | -0.29 | 47.48% | 80.00% | 2.973M | 918K | 223.86% | 142.69% |
| Q2 2024 | 0.25 | -0.45 | 155.70% | 350.00% | 1.158M | -100.00% | -100.00% | |
| Q1 2024 | -0.69 | -0.32 | -118.22% | -72.50% | 966K | 1.122M | -13.90% | 21.36% |
| Q4 2023 | -0.55 | -0.36 | -54.06% | -89.66% | 1.528M | 877.2K | 74.19% | 45.52% |
| Q3 2023 | -0.75 | -0.32 | -137.19% | -212.50% | 1.225M | 973.59K | 25.82% | -8.58% |
| Q2 2023 | -0.10 | -0.38 | 73.86% | 61.54% | 980K | 1.846M | -46.91% | -47.87% |
| Q1 2023 | -0.40 | -0.33 | -22.55% | -33.33% | 796K | 1.815M | -56.14% | -35.81% |
| Q4 2022 | -0.29 | -0.29 | -1.54% | -26.09% | 1.05M | 1.703M | -38.34% | 6.06% |
| Q3 2022 | -0.24 | -0.28 | 14.44% | -9.09% | 1.34M | 1.673M | -19.90% | 7.20% |
| Q2 2022 | -0.26 | -0.23 | -10.83% | -4.00% | 1.88M | 1.134M | 65.78% | 60.68% |
| Q1 2022 | -0.30 | -0.21 | -40.06% | -11.11% | 1.24M | 1.03M | 20.39% | 15.89% |
| Q4 2021 | -0.23 | -0.28 | 18.50% | 36.11% | 990K | 1.004M | -1.39% | 98.00% |
| Q3 2021 | -0.22 | -0.27 | 18.09% | 29.03% | 1.25M | 1.098M | 13.84% | 331.03% |
| Q2 2021 | -0.25 | -0.27 | 7.51% | 3.85% | 1.17M | 418.2K | 179.77% | 3,800.00% |
| Q1 2021 | -0.27 | -0.33 | 17.28% | 44.90% | 1.07M | - | - | |
| Q4 2020 | -0.36 | -0.30 | -20.32% | - | 500K | 207.06K | 141.48% | - |
| Q3 2020 | -0.31 | -0.24 | -28.42% | - | 290K | 594.997K | -51.26% | - |
| Q2 2020 | -0.26 | -0.38 | 31.72% | - | 30K | 765K | -96.08% | - |
| Q1 2020 | -0.49 | -0.30 | -62.84% | - | 510K | -100.00% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
20.54%
Max EPS beat (4)
119.61%
Min EPS beat (4)
-72.74%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-12.79%
Max Revenue beat (4)
54.05%
Min Revenue beat (4)
-65.13%
Analysis
In the last 4 quarters, ARMP has beaten EPS estimates in 2 out of 4 releases
ARMP has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, ARMP has beaten the EPS estimates by 20.5% on average.
In the last 4 quarters, ARMP reported -12.8% below the revenue estimates on average.
Related analysis
ARMATA PHARMACEUTICALS INC / ARMP Earnings FAQ
Did ARMP stock beat earnings estimates in the most recent quarter?
ARMATA PHARMACEUTICALS INC (ARMP) missed EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often ARMATA PHARMACEUTICALS INC beats earnings estimates?
In the last 4 quarters, ARMATA PHARMACEUTICALS INC (ARMP) has beaten EPS estimates in 2 out of 4 releases.